17-30834680-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024857.5(ATAD5):āc.599A>Cā(p.Asn200Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,610,112 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024857.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATAD5 | NM_024857.5 | c.599A>C | p.Asn200Thr | missense_variant | 2/23 | ENST00000321990.5 | NP_079133.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATAD5 | ENST00000321990.5 | c.599A>C | p.Asn200Thr | missense_variant | 2/23 | 1 | NM_024857.5 | ENSP00000313171 | P1 | |
ATAD5 | ENST00000578295.5 | c.599A>C | p.Asn200Thr | missense_variant | 2/15 | 1 | ENSP00000463102 | |||
ENST00000580873.1 | n.334-51T>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000650 AC: 16AN: 246316Hom.: 0 AF XY: 0.0000899 AC XY: 12AN XY: 133456
GnomAD4 exome AF: 0.0000453 AC: 66AN: 1457894Hom.: 2 Cov.: 34 AF XY: 0.0000579 AC XY: 42AN XY: 725044
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.599A>C (p.N200T) alteration is located in exon 2 (coding exon 2) of the ATAD5 gene. This alteration results from a A to C substitution at nucleotide position 599, causing the asparagine (N) at amino acid position 200 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at